Xtant Medical Holdings (XTNT) Raw Materials (2019 - 2025)

Xtant Medical Holdings (XTNT) has 7 years of Raw Materials data on file, last reported at $5.7 million in Q4 2025.

• On a quarterly basis, Raw Materials fell 14.09% year-over-year to $5.7 million in Q4 2025; TTM through Dec 2025 was $5.7 million, a 14.09% decrease from a year earlier, with the FY2025 full-year figure at $5.7 million, down 14.09% from the prior year.
• Raw Materials for Q4 2025 stood at $5.7 million, up from $5.6 million in the prior quarter.
• Over the last five years, Raw Materials for XTNT reached as high as $7.3 million in Q4 2023 and fell as low as $3.8 million in Q1 2021.
• Historically, Raw Materials has averaged $5.8 million across 5 years, with a median of $5.7 million in 2022.
• Across the five-year window, Raw Materials jumped 49.4% in 2021 and declined 23.22% in 2025, its largest moves.
• Year by year, Raw Materials stood at $5.6 million in 2021, then gained by 0.27% to $5.6 million in 2022, then climbed by 29.16% to $7.3 million in 2023, then fell by 8.9% to $6.6 million in 2024, then retreated by 14.09% to $5.7 million in 2025.
• Per Business Quant data, the three most recent Raw Materials figures were $5.7 million in Q4 2025, $5.6 million in Q3 2025, and $5.4 million in Q2 2025.